OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024
MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) --OPKO Health, Inc. (NASDAQ: OPK)plans to report operating and financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on Thursday, November 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on November 7thbeginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using thislink. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relationspageandhere.
A telephone replay will be available through November 14, 2024, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 6323665. A webcast replay will be available beginning approximately one hour after the completion of the live conference callhere.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visitwww.opko.com.
Contacts:
LHA Investor RelationsYvonne Briggs, 310-691-7100ybriggs@lhai.comorBruce Voss, 310-691-7100bvoss@lhai.com
Released October 29, 2024